Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Clin Oncol (R Coll Radiol) ; 26(6): 333-43, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24746747

ABSTRACT

AIMS: To investigate patterns of practice in palliative radiotherapy in Africa. MATERIALS AND METHODS: Fifteen centres in Africa provided detailed information about radiotherapy in both metastatic and locally advanced disease via a questionnaire. Information included general information (institution status, equipment, staff, patient number), radiotherapy and other treatment characteristics in bone metastasis, brain metastasis, metastatic spinal cord compression, lung and liver metastasis, as well as locally advanced tumours. RESULTS: The number of patients annually seen/treated ranged from 285 to 5000. Breast, cervix, head and neck, gastrointestinal and prostate cancer were the top five cancers overall. Eight (53%) institutions were without linear accelerators, four (27%) had a single one, whereas one institution each had two, three and four linear accelerators. The number of cobalt machines ranged from 0 to 2 (median 1). Most centres still prefer to use fractionated radiotherapy regimens over single-fraction regimens in bone metastasis, although most centres are now using single-fraction radiotherapy in retreatments. Radiotherapy in brain metastasis and metastatic spinal cord compression mostly conform to worldwide standards. Lung and liver metastases are rarely irradiated, largely as a consequence of the lack of modern radiotherapy technology. Locally advanced disease in various tumour sites was mostly palliated, in agreement with current evidence-based practices. CONCLUSIONS: African countries still lack adequate staffing and equipment to adequately address their clinical burden, being palliative in most cases. Emphasis should also be made on more rationally using existing capacities by using more of the single-fraction radiotherapy regimens, especially in bone metastasis.


Subject(s)
Neoplasm Metastasis/radiotherapy , Neoplasms/radiotherapy , Palliative Care/statistics & numerical data , Africa , Developing Countries , Dose Fractionation, Radiation , Female , Humans , Male , Palliative Care/methods , Surveys and Questionnaires
2.
Psychooncology ; 21(3): 332-5, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22383275

ABSTRACT

OBJECTIVE: The use of mobile phone as a tool for improving cancer care in a low resource setting. METHODS: A total of 1176 oncology patients participated in the study. Majority had breast cancer. 58.4% of the patients had no formal education; 10.7 and 9.5% of patients had college or graduate education respectively. Two out of every three patients lived greater than 200 km from hospital or clinic. One half of patients rented a phone to call. RESULTS: At 24 months, 97.6% (1132 patients) had sustained their follow-up appointments as against 19.2% (42 patients) who did not receive the phone intervention. 72.8% (14 102 calls) were to discuss illness/treatment. 14% of the calls were rated as emergency by the oncologist. 86.2% of patients found the use of mobile phone convenient/excellent/cheap. 97.6% found the use of the phone worthwhile and preferred the phone to traveling long distance to hospital/clinic. Also the patients felt that they had not been forgotten by their doctors and were been taken care of outside the hospital/clinic. CONCLUSIONS: Low resource countries faced with the burden of cancer care, poor patient follow-up and poor psychosocial support can cash in on this to overcome the persistent problem of poor communication in their healthcare delivery. The potential is enormous to enhance the use of mobile phones in novel ways: developing helpline numbers that can be called for cancer information from prevention to treatment to palliative care. The ability to reach out by mobile phone to a reliable source for medical information about cancer is something that the international community, having experience with helplines, should undertake with colleagues in Africa, who are experimenting with the mobile phone potential.


Subject(s)
Cell Phone , Delivery of Health Care/methods , Neoplasms/therapy , Patient Compliance , Telemedicine/methods , Adolescent , Adult , Aged , Aged, 80 and over , Communication , Female , Follow-Up Studies , Humans , Male , Middle Aged , Nigeria
3.
Niger Postgrad Med J ; 18(1): 34-3, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21445111

ABSTRACT

AIMS AND OBJECTIVES: To assess liver function in Nigerian cancer patients undergoing cytotoxic chemotherapy, with a view to contributing to the existing literature and possibly making recommendations for better management of the affected patients in Nigerian hospitals. PATIENTS AND METHODS: Serum levels of total bilirubin (TB), alanine amino transferase (ALT), aspartate amino transferase (AST), alkaline phosphatase (ALP), total protein (TP), albumin (ALB) and De Ritis ratio (AST/ALT) were determined in 50 cancer patients both before and after chemotherapy and 50 age- and sex-matched control individuals. The data obtained were analysed using Microsoft Office Excel 2003. Two-tailed student's t- test for matched samples and Pearson's linear correlation statistical methods were employed for the analyses. RESULTS: The levels of serum ALT, AST, ALP and TB, ALB, TP and AST/ALT were significantly higher in cancer patients than in controls both before and after chemotherapy, with more pronounced elevations after chemotherapy. There were positive and significant correlations between cycles of chemotherapy and the serum liver function tests. CONCLUSION: The findings from the present study conclude that there is slight difference when compared to controls in liver function test profile in cancer patients even before commencement of chemotherapy with a worsening of the profile of patients after chemotherapy. This difference in liver function also increases with the cycles of chemotherapy.


Subject(s)
Antineoplastic Agents/adverse effects , Chemical and Drug Induced Liver Injury/blood , Neoplasms/drug therapy , Adult , Aged , Alanine Transaminase/blood , Alkaline Phosphatase/blood , Aspartate Aminotransferases , Case-Control Studies , Chemical and Drug Induced Liver Injury/complications , Female , Hospitals, Teaching , Humans , Liver/enzymology , Liver/physiopathology , Male , Middle Aged , Neoplasms/complications , Nigeria
4.
Dis Esophagus ; 23(3): 240-3, 2010 Apr.
Article in English | MEDLINE | ID: mdl-19664077

ABSTRACT

While numerous surveys of pattern of practices of palliative radiotherapy (RT) in advanced esophageal cancers have been published in developed countries, there is no such survey in African countries. During and after a regional training course by the International Atomic Energy Agency (IAEA) in palliative cancer care, a questionnaire was distributed to African RT centers to gather information about infrastructure and human resources available, and the pattern of practice of palliative RT for esophageal cancers. Twenty-four of the 35 centers (60%) completed the questionnaire. Twenty out of 23 (87%) centers treat patients with esophageal cancer presenting with dysphagia using external beam RT (16 centers external beam RT alone and 4 centers also use brachytherapy as a boost). Twelve (60%) centers prescribe RT doses of 30 Gy in 10 fractions and 2 centers 20 Gy in 5 fractions. Eighteen centers (78%) have low dose rate (LDR) brachytherapy, and 9 (39%) centers have high dose rate (HDR) brachytherapy. One center only used HDR brachytherapy alone to a dose of 16 Gy in 2 fractions over 8 days. RT remains a major component of treatment of patients with esophageal cancers in African countries. Still, there is a great variety among centers in both indications for RT and its characteristics for a treatment indication.


Subject(s)
Esophageal Neoplasms/radiotherapy , Palliative Care/statistics & numerical data , Practice Patterns, Physicians'/statistics & numerical data , Radiation Oncology/organization & administration , Radiotherapy/statistics & numerical data , Africa , Esophageal Neoplasms/complications , Esophageal Neoplasms/pathology , Humans , Neoplasm Staging , Patient Selection
5.
Psychooncology ; 19(8): 893-7, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20025083

ABSTRACT

OBJECTIVES: Few studies have examined the psychosocial impact of breast cancer and its treatment on African women who come from a poverty-stricken, uneducated background in a developing country. The purpose of this study was to describe the specific psychosocial effects of breast cancer on married African women in order to help physicians educate and counsel future women and their families in Northwestern Nigeria. METHODS: Two semi-structured, self-report questionnaires were given to 81 consenting married African women treated with unilateral total mastectomy secondary to operable breast cancer at the Ahmadu Bello University Teaching Hospital. Questionnaires were answered at the time of the diagnosis and treatment consultation and at 6 months postmastectomy and included questions about demographics, frequency of conjugal relations and how the woman's sense of femininity was affected. Marital status was also tracked up to 3 years. RESULTS: Six months after surgery, the survey responses revealed that 67.9% of women felt inadequate as a woman because of the mastectomy and that 79.0% experienced a decrease in frequency of conjugal relations. Three years after primary breast cancer treatment, 61.7% of the participants were still married while 38.3% reported being divorced/separated from their husbands. CONCLUSIONS: These results indicated that married African women face significant physical, emotional and social changes and difficulties following primary breast cancer treatment. Culturally sensitive therapeutic groups and interventions should be established to help Nigerian women with breast cancer and their spouses and families understand and cope with the disease and its long-term health and quality-of-life implications.


Subject(s)
Black People/psychology , Breast Neoplasms/ethnology , Breast Neoplasms/psychology , Developing Countries , Marital Status , Mastectomy, Simple/psychology , Adolescent , Adult , Aged , Body Image , Breast Neoplasms/pathology , Breast Neoplasms/surgery , Divorce/psychology , Educational Status , Female , Follow-Up Studies , Gender Identity , Hospitals, University , Humans , Middle Aged , Neoplasm Staging/psychology , Nigeria , Poverty/psychology , Psychosocial Deprivation , Sexual Behavior , Social Support , Social Values , Surveys and Questionnaires , Young Adult
6.
Expert Rev Anticancer Ther ; 9(10): 1405-11, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19827999

ABSTRACT

Lung cancer is the leading cause of cancer mortality with the median age of incidence being 69 years in males and 67 years in females. Radiochemotherapy (RT-CHT) is indicated in locally advanced non-small-cell lung cancer and limited-stage small-cell lung cancer; however, a significant under-representation of the elderly has been observed in patient recruitment in cancer treatment trials. In the last decades of the 20th Century, studies showed that elderly patients achieved the best quality-adjusted survival with radiotherapy alone, but recent trials have found that fit elderly patients benefit from concurrent RT-CHT, although with more short-term toxicity. Age alone should not exclude fit patients and deprive them of the standard treatment. Using tools, such as comprehensive geriatric assessment, a patient's tolerance to therapy can be assessed and monitoring can be performed. This review will focus on RT-CHT treatment in elderly patients with nonoperable stage III non-small-cell lung cancer and limited-stage small-cell lung cancer exclusively.


Subject(s)
Carcinoma, Non-Small-Cell Lung , Carcinoma, Small Cell , Lung Neoplasms , Age Factors , Aged , Antineoplastic Agents/adverse effects , Antineoplastic Agents/therapeutic use , Carcinoma, Non-Small-Cell Lung/drug therapy , Carcinoma, Non-Small-Cell Lung/mortality , Carcinoma, Non-Small-Cell Lung/radiotherapy , Carcinoma, Small Cell/drug therapy , Carcinoma, Small Cell/mortality , Carcinoma, Small Cell/radiotherapy , Clinical Trials as Topic , Combined Modality Therapy , Female , Geriatric Assessment/methods , Humans , Lung Neoplasms/drug therapy , Lung Neoplasms/mortality , Lung Neoplasms/radiotherapy , Male , Neoplasm Staging , Survival Rate
7.
Clin Oncol (R Coll Radiol) ; 21(7): 536-42, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19403282

ABSTRACT

Radiochemotherapy has become a standard approach in locally advanced non-small cell lung cancer and limited disease small cell lung cancer. Most of the data supporting this observation come from the developed world and only extremely rarely have good-quality clinical trials been carried out in developing countries. It is therefore of paramount importance to put the experience of the developed world into the context of the limited resources and other health care problems of developing countries. In this overview, the problems with the implementation of such data are discussed. The necessity of carrying out clinical trials specifically designed to address the needs of developing countries is emphasised. The research on cheaper ways of radiochemotherapy combination should be encouraged. The specific national guidelines for local needs should be created and followed. The availability of radiotherapy equipment is of major importance, as radiotherapy has a pivotal role in non-surgical treatment of lung cancer, especially in the developing world.


Subject(s)
Lung Neoplasms/drug therapy , Lung Neoplasms/radiotherapy , Combined Modality Therapy , Developing Countries , Humans
8.
Niger Postgrad Med J ; 16(1): 35-9, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19305436

ABSTRACT

OBJECTIVE: To study the clinicopathological characteristics of Colorectal Cancer (CRC) in the Guinea Savannah region; identify sub site; ascertain any change in the anatomical sub-site between 1981-2005; relate tumour stage/differentiation, to age young =40 years and = 41years old patients Highlight option for diagnosis in the sub region. SETTING: There were 262 patients consisting of 125 retrospective and 137 prospective cases seen in the premier tertiary health institution in Northern Nigeria. RESULTS: The Male:Female ratio = 1.37:1, mean age 39.8 years, cluster age group 3rd-6th decade( 82.1%), patients = 40years constituted 48.2% . Main clinical features present for more than 6 months were bloody mucus discharge (83.5%), palpable rectal mass (67.9%), pain (67%), tenesmus (60.1%). Ignorance of the disease was rife amongst non-specialists, spiritualists and the patients. The left colon was eleven times more commonly affected than the right colon. The rectum was the commonest sub site (74.3%). In 2 out of every 3 patients, the tumour was digitally palpable per rectum. There was no shift in the distribution sub site in (1981-1990), and (1991-2005). 97.2% the tumours were adenocarcinoma. 68.9% patients had advanced disease Duke C or D. 3 out of every 4 patients (= 40 years age group) had advanced disease. Histological prognostic grade of tumour was inversely related to =40 years age group. Routine digital rectal examination as an investigative armamentarium,and public awareness may reduce the prevalence of advanced CRC in the low resource subregion,we advocate their use.


Subject(s)
Colorectal Neoplasms , Colorectal Neoplasms/epidemiology , Guinea , Humans , Nigeria/epidemiology , Prospective Studies , Retrospective Studies
9.
Niger. j. surg. (Online) ; 12(1-2): 28-30, 2006.
Article in French | AIM (Africa) | ID: biblio-1267496

ABSTRACT

Background: The etiology of radiation recall phenomenon is not well understood. Adriamycin - based cytotoxics are frequently being used as adjuvant chemotherapy in breast cancer treatment in our environment. The phenomenon also occurs in association with radiation. Method: In our search of African literature; there seems to be a paucity of radiation - recall dermatitis and pneumonitis among Africans. We describe the case of a patient with breast cancer that developed radiation recall dermatitis and pneumonitis; secondary to the administration of adriamycin - based cytotoxic chemotherapy. Conclusion: This phenomenon should be considered as a differenial diagnosis of dermatitis and pneumonitis in patients receiving anthracycline - based cytotoxics


Subject(s)
Anti-Bacterial Agents , Antineoplastic Agents , Case Reports , Dermatitis/diagnosis , Dermatitis/etiology , Pneumonia
SELECTION OF CITATIONS
SEARCH DETAIL
...